Dosing Mix-up Raises Questions About New COVID Vaccine Unlisted Video
3 years ago
236
A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed.
The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford.
Less than a week after we learned about it, the developers have admitted to a manufacturing error.
The error resulted from two different doses during the recently concluded phase III trial.
AstraZeneca and the University of Oxford described the vaccine as being 70% effective.
However, that number now seems a bit misleading but not necessarily in a bad way.
Loading 1 comment...
-
0:41
KTNV
3 years agoAntibody lifespan raises questions on vaccine protection
80 -
2:25
WGBA
3 years agoMeat plant worker raises questions about safety
64 -
2:16
KTNV
3 years agoUS remembers Ginsburg, Trump raises questions about honoring election results
236 -
0:41
Newsy
3 years agoWorld Series Celebration Raises Questions After Positive COVID Test
3281 -
1:40
WFTX
3 years agoCOVID vaccine distribution plans
4.05K4 -
0:30
KTNV
3 years agoNew questions about TikTok loophole
1611 -
0:39
WFTX
3 years agoCOVID vaccine could be seasonal
2.77K8 -
4:44
KNXV
3 years agoNew questions about school benchmarks
23 -
2:01
WFTX
3 years agoCovid vaccine distribution plan
1.32K3 -
1:59
KIVI
3 years agoWhen Will Idaho Receive COVID Vaccine?
1.04K